Skip to main content

Want a detailed portfolio tracker?

Nanobiotix (NBTX) P/E (2020 - 2026)

Nanobiotix (NBTX) P/E from Dec 11, 2020 to Jun 3, 2026. The TTM Nanobiotix (NBTX) P/E is -16.39. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nanobiotix (NBTX)

YearP/EChange
2026-16.39+52.25%
2025-10.77+594.33%
2024-1.55-48.51%
2023-3.01+129.24%
2022-1.31-35.70%
2021-2.04-41.74%
2020-3.51N/A

Comparison Nanobiotix (NBTX) P/E with competitors

Nanobiotix (NBTX) P/E is -16.39.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.62%
ENLVEnlivex Therapeutics Ltd0.15-100.92%
FGENFibroGen Inc0.24-101.46%
TRAWTraws Pharma Inc0.47-102.88%
FBIOFortress Biotech Inc0.71-104.31%
CHRSCoherus Biosciences Inc0.98-105.97%
ORMPOramed Pharmaceuticals Inc1.47-108.99%
AGENAgenus Inc2.05-112.50%
VIVSVivoSim Labs Inc2.54-115.47%
INVAInnoviva Inc3.19-119.45%
CRMDCorMedix Inc3.65-122.24%
ABEOAbeona Therapeutics Inc4.20-125.65%
VXRTVaxart Inc4.26-126.00%
CVACCureVac N.V.4.45-127.12%
SRPTSarepta Therapeutics Inc4.62-128.21%
GLPGGalapagos NV4.86-129.64%
RIGLRigel Pharmaceuticals4.92-130.01%
ZVRAZevra Therapeutics Inc4.97-130.34%
ABUSArbutus Biopharma Corp5.69-134.73%
CGENCompugen Ltd7.38-145.04%
AUPHAurinia Pharmaceuticals Inc9.25-156.43%
ACADAcadia Pharmaceuticals Inc9.59-158.49%
OMEROmeros Corporation9.88-160.29%
PLXProtalix BioTherapeutics Inc9.91-160.45%
SPROSpero Therapeutics Inc10.73-165.48%
ADMAAdma Biologics Inc11.33-169.12%
SVASinovac Biotech Ltd11.44-169.76%
TBPHTheravance Biopharma Inc11.78-171.84%
HRMYHarmony Biosciences Holdings Inc12.18-174.30%
TGTXTG Therapeutics Inc13.18-180.40%
INCYIncyte Corp13.38-181.63%
SABSSAB Biotherapeutics Inc14.06-185.75%
XOMAXOMA Corp14.95-191.17%
REGNRegeneron Pharmaceuticals Inc14.98-191.38%
PBYIPuma Biotechnology Inc15.05-191.81%
EXELExelixis Inc15.79-196.35%
CPRXCatalyst Pharmaceuticals Inc17.34-205.81%
MDXGMimedx Group Inc17.38-205.99%
ARGXArgen X SE23.07-240.74%
HALOHalozyme Therapeutics Inc23.20-241.53%
XOMAOXOMA Corp25.34-254.61%
VRTXVertex Pharmaceuticals Inc25.66-256.50%
XOMAPXOMA Corp25.67-256.59%
CTMXCytomX Therapeutics Inc25.70-256.76%
ASNDAscendis Pharma A/S26.35-260.76%
RPRXRoyalty Pharma plc - Class A27.50-267.73%
SLNOSoleno Therapeutics Inc29.02-277.00%
LGNDLigand Pharmaceuticals Inc - Class B30.19-284.14%
BMRNBiomarin Pharmaceutical Inc37.51-328.80%
APLSApellis Pharmaceuticals Inc39.02-338.03%
KRYSKrystal Biotech Inc39.70-342.16%
GMABGenmab40.20-345.25%
ONCBeiGene Ltd67.03-508.87%
TECHBio-Techne Corp68.59-518.44%
VCELVericel Corp80.63-591.85%
PHARPharming Group N.V.87.74-635.23%
ALNYAlnylam Pharmaceuticals Inc124.93-862.11%
TLXTelix Pharmaceuticals Ltd139.89-953.35%
CORTCorcept Therapeutics Inc158.39-1066.20%